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ABSTRACT
Vascular cognitive impairment (VCI) is a common condition in which no standard treatment 
has been approved. VCI is often accompanied by behavioral problems which require 
psychiatric interventions. The common therapeutic agent used for the acute management 
is antipsychotic injections. Current findings showed that atypical antipsychotic possess 
better safety profile for treating behavioral problems related to VCI compared to typical 
antipsychotic. In this study, we induced VCI in Sprague Dawley rats between 6-8 weeks 
old using bilateral carotid communist artery occlusion technique. The subjects were divided 
into 4 treatment groups: sham, olanzapine, haloperidol, and risperidone groups. Subjects 
received intramuscular injections of subsequent drugs for 3 days post VCI induction. 
Impulsive behavior and object recognition were examined using cliff jumping test and 
novel object recognition test. The analyses results showed that impulsive behavior was 
lower in the olanzapine and haloperidol groups compared to sham group, although it was 
not statistically significant (p = 0.651). The results also showed that there were no 
significant differences in the time spent exploring old and novel objects in all groups (p = 
0.945;0.637 respectively). In conclusion, antipsychotic injection might not be effective 
to control impulsive behavior post VCI induction.
ABSTRAK 
Vascular cognitive impairment (VCI) merupakan kondisi patologi dengan prevalensi 
tinggi namun belum ada terapi standar yang telah disetujui. VCI sering disertai dengan 
gangguan perilaku yang membutuhkan penanganan psikiatri. Agen terapi yang digunakan 
pada penanganan akut adalah injeksi antipsikotik. Saat ini antipsikotik atipikal dikatakan 
lebih baik untuk digunakan dalam penanganan gangguan perilaku akibat VCI dibandingkan 
antipsikotik tipikal. Dalam penelitian ini, kami menginduksi VCI pada tikus Sprague 
Dawley berumur 6-8 minggu dengan tehnik bilateral carotid communist artery occlusion. 
Subyek dibagi menjadi 4 kelompok terapi, yaitu kelompok sham, olanzapine, haloperidol, 
dan risperidone. Subyek mendapatkan obat bentuk injeksi intramuskular sesuai dengan 
kelompok selama 3 hari pasca induksi VCI. Perilaku impulsif dan kemampuan mengenali 
obyek diperiksa dengan cliff jumping test dan novel object recognition test. Analisa cliff 
jumping test menunjukkan bahwa perilaku impulsif kelompok olanzapine dan haloperidol 
lebih rendah dibandingkan sham, meskipun tidak bermakna secara statistik. Hasil analisa 
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INTRODUCTION
Vascular disruption might induce cerebral 
damages, particularly ischemic lesions. The 
brain will experience a series of alterations 
including infarct evolvement, cellular 
proliferation in the penumbra, and behavioral 
deficits.1 The term vascular cognitive 
impairments (VCI) had been coined to account 
for behavioral and psychological symptoms 
that were induced by vascular disruptions. 
The common components are of behavioral, 
affective, psychotic, and somatic symptoms.2 
The most common cause of psychiatric 
consultation however, was violent impulsive 
behavior, particularly in early phase of the 
disorder.
VCI is a common condition for 
which there are no effective approved 
pharmacological treatments available. It is 
recommended that non pharmacological 
intervention should be tried first in the 
management of behavioral problems related 
to VCI. However, if the symptoms are severe 
and non pharmacological interventions failed 
to address the problems, short term treatment 
using antipsychotics are recommended.2,3 
Antipsychotics exert neuroprotective effects 
against cell death due to environmental 
stressors. Olanzapine and risperidone, but not 
haloperidol, stimulated neurogenesis in rat 
brain areas (e.g. hippocampus) and preserved 
cholinergic pathways and cognitive function, 
possibly by increasing levels of nerve 
growth factor.4-6 The typical antipsychotic, 
haloperidol, have been widely used partly due 
to its cheap price and wide distribution. Its 
efficacy is compromised by its long term side 
effect on cognitive functions. It is therefore 
atypical antipsychotics which have better 
safety profile have gradually been considered 
as a better option. Atypical antipsychotics 
have been reported to attenuate both cognitive 
and non-cognitive behavioral impairments 
in different animal models of neurotoxicity. 
Their beneficial behavioral effects are not 
only related to their dopamine and serotonin 
receptor blockade effects, but also to their 
effects on neuroprotection, neurotrophins and 
neurogenesis.7
To assess the efficacy of antipsychotics, 
animal models have been used. If the 
animal model is to be used to understand 
pathogenic mechanisms, the animal model 
should mimic as closely as possible the 
symptoms, neuropathology, and mechanisms 
of the disease. Conversely, if the purpose is to 
demonstrate the potential efficacy of a drug, 
the animal model could be less complex.8 
In this study, we used a global ischemia 
induction technique to mimic VCI which has 
been reported elsewhere.9-13
Although have been widely used, both 
typical and atypical antipsychotics use for VCI 
is mostly based on empirical data and expert 
opinions. Evidence of their efficacy to control 
behavioral problems and preserve cognitive 
function is scarce. In this study, we treated rat 
models of VCI with injections of short acting 
typical antipsychotic (haloperidol), short acting 
atypical antipsychotic (olanzapine), long 
statistik menunjukkan tidak ada perbedaan waktu yang dihabiskan untuk mengeksplorasi 
obyek lama dan obyek baru pada semua kelompok. Kesimpulan, injeksi antipsikotik dapat 
mengendalikan perilaku impulsif pasca induksi VCI.
Keywords: vascular cognitive impairment - antipsychotics - impulsive behavior–object 
recognitio 
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acting atypical antipsychotic (risperidone), 
and injection of aquabidest for the sham 
group.. We observed impulsive behavior and 
object recognition after treatments. 
METHODS
This study is a quasi experimental study. 
All subjects underwent surgery to induce 
global ischemia, modeling a VCI condition. 
The subjects were then divided into 4 groups: 
sham, olanzapine, haloperidol, and risperidone 
groups. Each group received designated 
treatment after VCI induction for three days 
(day 1, 2, and 3 after surgery). At day 4, 
subjects underwent behavioral examination. 
The protocol of this study was approved by the 
Ethical Committee of the Faculty of Medicine 
Universitas Gadjah Mada, Yogyakarta (ethical 
approval ref KE/FK/573/EC/2016).
Subjects
The subjects of this study were male 
Spague Dawley rats age 6-8 weeks old. The 
weight was between 200-250 gram. All 
subjects received the same treatments aside 
from the drug used. 
VCI induction
VCI was induced using bilateral 
common carotid artery occlusion (BCCAO) 
technique. The animals were anesthetized by 
intramuscular (i.m) injection of ketamin (10 
mg/kg) and both common carotid arteries 
were carefully separated from the cervical 
sympathetic and vagal nerves through a ventral 
cervical incision. The bilateral common 
carotid arteries were exposed, isolated and 
clamped for 20 min. 9,13
Drugs administration
After VCI induction, the subjects were 
divided into four groups, that is sham, 
olanzapine, haloperidol, and risperidone 
groups. The sham group received i.m injection 
of 1 cc aquabidest. The olanzapine group 
received i.m injection of Zyprexa (olanzapine, 
Eli Lilly). The haloperidol group received i.m 
injection of Lodomer (haloperidol lactate, 
Mersifarma). The risperidone group received 
i.m injection of Risperdal Consta (long acting 
risperidone, Janssen). Subjects received single 
injection per day for three days.
Behavioral examinations
There were two behavioral traits 
measured in this study, impulsivity and object 
recognition. Within 24 hours after treatment 
completion, subjects were checked for 
impulsive behavior using cliff jumping test. 
Each subject was placed on 10x10 cm stage 
placed 30 cm high for 5 minutes. Since rats 
are afraid of height, normally they will not 
jump off the stage. Impulsive behavior was 
established if subject jump off the stage during 
the experiments.14
Novel object recognition test (NORT) 
was used to test for short term memory and 
object recognition. The test was conducted 
in two phase. In the first phase, subjects were 
allowed to explore freely in a 40x40 cm box 
with an object inside the box (old objects). 
After 5 minutes, a new different object would 
be introduced (novel object) in the second 
phase. Rats are curious animal which will 
explore objects they are not familiar with 
hence they will spend more time exploring 
the new object. The time spent exploring the 
old and novel objects during the second phase 
were measured.15
Data analysis
The data was analyzed using SPSS ver. 
17. Cochran Q analysis was used compared 
proportion of impulsive subjects between 
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the treatment groups. Mann Whitney test was 
used to analyze if there were differences in the 
time spent exploring old and novel objects in 
each groups. Kruskal Wallis test was used to 
analyze if there were differences in the time 
spent exploring old and novel objects between 
groups. Significant level was defined at p < 
0.05. 
RESULTS
The cliff jumping test results analysis 
showed that there was no significant difference 
in impulsive behaviors across treatment 
groups. Olanzapine and haloperidol groups 
showed lower rate of impulsive behavior 
compared to sham group. On the contrary, 
risperidone group showed higher rate of 
impulsive behavior compared to sham group 
(TABLE 1). 
TABLE 1. Impulsive behavior based on cliff jumping test results
Behavior
Groups Cochran’s Q
Sham Olanzapine Haloperidol Risperidone χ2 df p
Non-impulsive 4(0.44) 4(0.57) 4(0.57) 3(0.38) 1.636 3 0.651
Impulsive 5(0.55) 3(0.43) 3(0.43) 5(0.63)
We analyzed if there were any differences 
in time spent exploring old and novel objects 
for each group. The sham groups spent almost 
equal amount of time exploring old and novel 
objects. Olanzapine and haloperidol groups 
spent more time exploring old objects. Subjects 
in the risperidone groups spent more time 
exploring novel objects. Nevertheless, these 
differences were not statistically significant 
(TABLE 2). Next we analyzed if there were 
any differences in time spent exploring old 
and novel objects between groups. There were 
no significant differences between the groups 
(TABLE 3). 
TABLE 2.  Analysis of the time spent exploring old and novel objects in the novel object recognition test 
for each treatment group using Mann Whitney test
Groups
Mean (seconds) Mann Whitney test
Old Novel Z p
Sham 26.24 + 23.49 23.38 + 25.36 0.530 0.596
Olanzapine 37.31 + 55.52 25.4 + 26.24 0.064 0.952
Haloperidol 36.34 + 59.73 13.28 + 27.74 0.721 0.472
Risperidone 51.40 + 76.40 83.61 + 111.71 0.105 0.959
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TABLE 3.  Analysis of the time spent exploring old and novel objects in the novel 
object recognition test between treatment groups using Kruskal Wallis 
test
Objects
Mean (seconds)
X2
df
Kruskall Wallis
P
Old
Sham 26.24 + 23.49 0.375 3 0.945
Olanzapine 37.31 + 55.52
Haloperidol 36.34 + 59.73
Risperidone 51.40 + 76.40
Novel 
Sham 23.38 + 25.36 1.702 3 0.637
Olanzapine 25.4 + 26.24
Haloperidol 13.28 + 27.74
Risperidone 83.61 + 111.71
DISCUSSION
In this study, we developed a rat model 
of VCI using bilateral carotid communist 
artery ligation. We found that impulsive 
behavior was lower in the groups treated 
with olanzapine and haloperidol, although it 
was not statistically significant. There was 
also no significant difference in the objects 
recognition test.
Although antipsychotics are among the 
most effective drugs used in the maintenance 
of schizophrenia, mania, and acute psychotic 
reactions, they are also indicated for several 
other indications, such as delusional 
disorders, borderline psychoses, neurological 
conditions, or behavioral disturbances. But 
studies in these other indications have been 
less comprehensive and often limited to 
particular antipsychotics. The use of typical 
antipsychotics in the elderly, age group in 
which VCI most common, is strongly limited 
by severe and intolerable side effects.16 
Therefore atypical antipsychotics are 
considered to be a better option. 
Patients with behavioral problems related 
to VCI usually cannot take medication 
orally. In this condition, injection of short 
acting antipsychotics becomes recommended 
solution. In Indonesia, only two short acting 
antipsychotic injection available. They are 
haloperidol and olanzapine injections, both 
of which have been widely use in VCI. In 
this study, we also administered long acting 
risperidone. It has been reported that a small 
amount of risperidone (+ 1%) is released into 
bloodstream within 24 hours after injection.17
Haloperidol and olanzapine reach peak 
concentration within 1 hour after injection and 
provide immediate control of the symptoms. 
But they require multiple injections, causing 
inconveniences toward the patients. Unlike 
haloperidol and olanzapine, the administration 
of risperidone only requires single injection 
of the drugs. In this study we showed that 
both haloperidol and olanzapine have better 
control over impulsive behavior compared 
to risperidone. This was because risperidone 
have not reach peak concentration and exerted 
its antipsychotic property. 
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In this study, the treatments were 
administrated in the first 3 days after VCI 
induction. Our aim was to limit the cerebral 
damage as shown by lower behavioral 
deficits. It was reported previously that 2 to 
4 after ischemia,1 emphasizing the importance 
of proper treatment in this period. The 
administration of antipsychotics in this period 
protected the brain from further damages, 
hence better preserving cognitive functions.4 
Nevertheless we failed to find any significance 
difference in the object recognition. The sham 
group spent equal amount of time exploring 
old and novel objects, olanzapine and 
haloperidol groups spent more on old objects, 
and risperidone group spent more time on 
novel objects.
Due to cognitive impairment, subjects in 
the shame group could not discriminate the 
novel from the old objects and spent equal 
amount of time exploring both. Spending 
more time on the old objects could be a sign 
of both anxiety and cognitive impairment. 
Due anxiety, subjects in the olanzapine and 
haloperidol groups spent more time on objects 
they’re most familiar with to feel secure. 
While subjects in the risperidone group were 
more explorative, suggesting hyperactivity 
which is a typical finding in VCI.
CONCLUSION
We found that antipsychotic injections 
might not be effective to control impulsive 
behavior post VCI induction. Nevertheless 
our findings showed that injections with 
short acting antipsychotic were better in 
controlling impulsivity compared to long term 
antipsychotic. Although in the long run, long 
term atypical antipsychotic might give better 
outcome. But this need to be further studied. 
Atypical antipsychotics are considered to have 
better safety profile, particularly in elderly, 
compared to typical.7,16 In the case of VCI in 
which the patients are mostly elderly, every 
antipsychotic treatment must be prescribed at 
the lowest effective dosage and for the shortest 
period possible.16
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